Arcutis Biotherapeutics Inc
ARQT
$25.11-3.94%
Delayed · as of Sep 17, 2026, 10:02 AM ET
Mkt cap
$1.64B
EV/Sales
4.54
P/E ratio
N/A
FY2025 Revenue
$376.07M
EPS (H1 2026)
$0.03
Gross Margin (FY2025)
90.24%
Profit Margin (FY2025)
-4.29%
Beta
1.78
Div yield
N/A
Sector
Healthcare
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
Latest reported ARQT revenue for 2025-12-31 was $376.1M. Net income was -$16.1M. Revenue was up 91.3% from 2024-12-31 to 2025-12-31. ARQT currently screens at market cap $1.64B.
Use this ARQT research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ARQT income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company in the Healthcare sector.
Latest cached Arcutis Biotherapeutics Inc (ARQT) revenue for Dec 31, 2025 was $376.1M. Net income was -$16.1M. Statements: https://lician.com/financials/arqt
Arcutis Biotherapeutics Inc (ARQT) market capitalization is $1.64B on the latest cached snapshot.
Arcutis Biotherapeutics Inc (ARQT) cached previous close $26.14; day range $24.42 – $25.95; volume 506,293. Session quote: https://lician.com/quote/arqt
Arcutis Biotherapeutics Inc (ARQT) latest cached earnings event is "ARQT earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ARQT filing is 8-K · Jul 16, 2026. Filings: https://lician.com/sec/arqt